(Corrects to removes share price milestone in paragraph 10)
* FTSE 100 up 0.4 pct
* FTSE 250 down 0.1 pct
* Micro Focus top blue-chip gainer after results
* AstraZeneca rises on Q4 sales beat, strong forecast
* ConvaTec slumps on mid-caps
Feb 14 (Reuters) - Britain's main index on Thursday held onto a more than four-month high hit in the last session, aided by earnings-driven gains in drugmaker AstraZeneca and software firm Micro Focus and boosted by forecast-beating trade data from China.
AstraZeneca AZN.L rose 3.8 percent on track for its best day since early November after its fourth-quarter product sales beat expectations and it forecast sales growth for 2019. Focus MCRO.L jumped 11.4 percent, the biggest blue-chip gainer, after its annual pro-forma revenue fell less-than-expected. Prime Minister Theresa May returns to parliament on Thursday to seek renewed backing for her plan to renegotiate her Brexit deal with Brussels, just weeks before the March 29 leave date and amid warnings over the risk of a disorderly exit. were also digesting data showing China's exports unexpectedly grew while imports fell much less than expected in January. A report that U.S. President Donald Trump was considering an extension of the March 1 deadline for higher tariffs on Chinese imports also helped the mood. the main bourse was Coca Cola HBC CCH.L which slipped 7 percent after it warned economic growth would slow in many of its markets this year. Shares were on track for their worst day in more than three-and-a-half years.
The mid-caps saw steep, news-related moves as well.
Medical device maker ConvaTec CTEC.L tanked nearly 20 percent as it reported lower annual operating profit. It launched a turnaround programme to boost revenue and cut costs in response to the bleak results. & Benny's owner Restaurant Group RTN.L skidded 11 percent after the company said its chief executive officer was stepping down due to "extenuating personal circumstances". Moneysupermarket.com MONY.L added 6.2 percent after it said it was confident of delivering market expectations for the year and also announced a chairman transition.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.